Simultaneous Occurrence of Upgrading and Downgrading Type 1 (Lepra) Reaction

V. Sehgal,S. Bhattacharya,V. Sharma,Rajinder P. Mathur
DOI: https://doi.org/10.1111/j.1365-4362.1990.tb04761.x
1990-06-01
International Journal of Dermatology
Abstract:A 35-year-old man, an established borderline borderline (BB) leprosy patient' since Feb. 1988, on multidrug therapy comprising 100 mg of dapsone, 50 mg of clofazimine, and 600 mg of rifampicin daily, reported in August 1988 with progressively increasing redness and swelling over the lesions of the face. The episode was symptom free. During the period, he had stopped reporting at the followup leprosy clinic and decided to take the opinion of another specialist, who advised him to stop the specific drugs and administered oral betamethasone 1.5 mg daily in three equally divided doses. With this treatment, the lesions continued to deteriorate, resulting in further exacerbation and involvement of all existing lesions and appearance of fresh lesions over an apparently normal skin. The reaction on the face, in particular, was violent. During betamethasone therapy, he had developed polyuria; however, history of polyphagia and polydipsia was absent. Examination of the left cheek was marked by a well-circumscribed shiny plaque, 1 1 X 8 cm. Erythema and edema were prominent. Tenderness was conspicuous by its absence, as were the tenderness and thickening of regional cutaneous nerves. Sensation of temperature was lost, but touch and pain were preserved. In all, there were 32 such plaques. The bacteriologic index (B.I.) was 3-4.
What problem does this paper attempt to address?